from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1668c/-

LFCtreatmentdescriptionclass of inhibitor

-0.446

Amikacinug/mL Amikacintranslation

-0.577

Cap5-10ug/mL Capreomycintranslation

-0.492

Rox10-50 ug/mL Roxithromycintranslation

-1.536

SM2-5 ug/mL Streptomycintranslation

-1.522

Tet5-10 ug/mL Tetracyclinetranslation

0.190

Rif0.2-5ug/mL Rifampicintranscription

0.550

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.719

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.334

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.464

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.269

Clofazimine10-13 ug/mL Clofaziminerespiration

0.250

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.752

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.285

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.105

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.379

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.719

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.267

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.545

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.490

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.038

KCN5-20 ug/mL Potassium cyaniderespiration

0.461

NaN30.2-2 mM Sodium aziderespiration

0.185

Nigericin50 uM Nigericinrespiration

-0.554

TRC10-150 ug/mL Triclosanrespiration

-1.284

TRZ10-25 ug/mL Thioridazinerespiration

-1.122

Valinomycin0.5-10 uM Valinomycinrespiration

-1.419

ZnSO42 mM ZnSO4respiration

0.581

menadione6-10 ug/mL Menadionerespiration

-0.091

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.505

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.051

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.546

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.051

NRP_1Non-replicating persistence stage 1dosRassociated

0.260

Amp0.2mg/mL AmpicillincellWall

0.276

Cephalexin20-100 ug/mL CephalexincellWall

0.524

Cerulenin0.32-5 ug/mL CerulenincellWall

0.464

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.216

EMB10-20 ug/mL EthambutolcellWall

0.521

Eta12-40 ug/mL EthionamidecellWall

0.220

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.609

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.265

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.440

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.140

BZA0.12 mg/mL BenzamidearomaticAmides

0.138

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.033

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.197

H2O24 mM hydrogen peroxideDNAdamaging

0.293

Levo10 ug/mL LevofloxacinDNAdamaging

0.456

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.933

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.150

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.273

UVUV-irradiationDNAdamaging

-0.858

ARP41-4 ug/mL Antitubercular compound ARP4?

0.254

Antimycin12.5-50 ug/mL Antimycin A?

0.003

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.953

PA_110-50 ug/mL Antitubercular compound PA-1?

0.055

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.410

PA8240.2-2 ug/mL PA-824?

-0.220

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.234

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.278

Verapamil50 uM Verapamil?

-0.294

mercaptoethanol2 mM 2-Mercaptoethanol?

0.569

methoxatin10-20 ug/mL Methoxatin?